Fast Track Anaemia Clinic (FTAC) and Intravenous Iron Administration: Its Relevance and Application Today in India

  • Kanjaksha Ghosh


Quintana-Díaz et al. [1] published a recent article on the above topic along with a very balanced editorial perspective on that paper by Girelli et al. [2]. They demonstrated that referring probable iron deficiency anaemia cases from emergency departments to FTAC for evaluation and intravenous iron administration of Iron Carboxy Maltose (ICM) saves time, money, avoids blood transfusion along with protection from all its attendant infectious and non infectious side effects leading to better clinical outcome of the patients in Spanish health care system.

In spain prevalence of iron deficiency anaemia was only 1–2.5% increasing to up to 10% in women of child bearing age [3]. However in India this prevalence is very high, up to 53% of women of child bearing age and up to 23% of adult males in recent National Family Health Survey [4]. In addition to anemia Iron deficiency without anaemia must also be present in the population in huge numbers with all its undesirable consequences [5]....


Compliance with Ethical Standards

Conflict of interest

The author declares that he has no conflict of interest.


  1. 1.
    Quintana-Díaz M, Muñoz-Romo R, Gómez-Ramírez S, Pavía J, Borobia AM, García-Erce JA, Muñoz M (2017) A fast-track anaemia clinic in the Emergency Department: cost-analysis of intravenous iron administration for treating iron-deficiency anaemia. Blood Transfus 15:438–446PubMedPubMedCentralGoogle Scholar
  2. 2.
    Girelli D, Marchi G, Busti F (2017) Iron replacement therapy: entering the new era without misconceptions, but more research needed. Blood Transfus 15:379–381PubMedPubMedCentralGoogle Scholar
  3. 3.
    Bilbao J (2006) AnemiascarencialesI anemia feropenica. Información Terapéutica del Sistema Nacional de Salud 30:35–41Google Scholar
  4. 4.
    India Fact Sheet: National Family and Health Survey-4(NFHS-4) 2015-2016. Fact sheet National Data page-6. International Institute of Population Science, Mumbai, India. Ministry of Health and family Welfare Govt of India. New Delhi, IndiaGoogle Scholar
  5. 5.
    Ghosh K (2006) Non haematological effects of iron deficiency—a perspective. Indian J Med Sci 60:30–37CrossRefPubMedGoogle Scholar
  6. 6.
    Anand G, Schmid C (2017) Severe hypophosphataemia after intravenous iron administration. BMJ Case Rep 2017. doi: 10.1136/bcr-2016-219160 Google Scholar
  7. 7.
    Schaefer B, Würtinger P, Finkenstedt A, Braithwaite V, Viveiros A, Effenberger M, Sulzbacher I, Moschen A, Griesmacher A, Tilg H, Vogel W, Zoller H (2016) Choice of high-dose intravenous iron preparation determines hypophosphatemia risk. PLoS ONE 11(12):e0167146. doi: 10.1371/journal.pone.0167146 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Gupta R, Gupta A (2014) Vitamin D deficiency in India: prevalence, causalities and interventions. Nutrients 6:729–775CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Gorakshkar AC, Ghosh K (2012) Subclinical iron deficiency is a silent epidemic amongst voluntary blood donors. Transfus Med 22:300–301CrossRefPubMedGoogle Scholar
  10. 10.
    Dara RC, Marwaha N, Khetan D, Patidar GK (2016) A randomized control study to evaluate effects of short-term oral ironsupplementation in regular voluntary blood donors. Indian J Hematol Blood Transfus 32:299–306CrossRefPubMedGoogle Scholar
  11. 11.
    Camaschella C (2015) Iron deficiency: new insights into diagnosis and treatment. Hematol Am Soc Hematol Educ Progr 2015:8–13Google Scholar
  12. 12.
    Bager P, Hvas CL, Dahlerup JF (2017) Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions. Br J Clin Pharmacol 83(5):1118–1125CrossRefPubMedGoogle Scholar

Copyright information

© Indian Society of Haematology & Transfusion Medicine 2017

Authors and Affiliations

  1. 1.Surat Raktadan Kendra and Research CentreSuratIndia

Personalised recommendations